Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06716931 · ClinicalTrials.gov registry record · NA
Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)
A NA study of Myotonic Dystrophy 2, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06716931 is a NA study of Myotonic Dystrophy 2 that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06716931, a NA study of Myotonic Dystrophy 2, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle composition in DM2 in this two-period two-sequence cross-over study. Thus, participant will be randomized to one of the three possible groups. Participants in GROUP A will perform exercise routine in clinic under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP B will perform exercise routine virtually under the direct supervision of a physical therapist twice a week for the first three months, then they will continue with same exercise routine at home for the last 3 months on their own. Participants in GROUP C will perform exercise routine on their own during the first 3 months, then they will perform exercise routine virtually under the direct supervision of a physical therapist. Each group will include around 8 participants. Duration of the study is 6 months. In addition to exercise sessions, participants will have evaluation of their strength, motor function and muscle composition at three time points: initiation, 3 months and completion of the study at 6 months. Muscle composition will be assessed by electrical impedance myography which is a portable, non-invasive, painless and non-radiation tool that applies a weak high multifrequency electrical current to the examined muscle and allows to obtain information about its composition.
Conditions Studied
Interventions
- OTHER Exercise
Study Locations (1)
Massachusetts
- Neuromuscular Diagnostic Center. Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-03-04 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06716931
The ClinicalTrials.gov registry entry for NCT06716931 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myotonic Dystrophy 2 appearing as the primary indexed condition, and to 1 intervention - of which Exercise is the first listed.
NCT06716931 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06716931 about?
NCT06716931 is a clinical study titled "Investigating Exercise in Myotonic Dystrophy Type 2 (DM2)". An exercise regimen (PRIME: Proximal Resistance In-House Movement Exercise) has been designed for patients with myotonic dystrophy type 2 (DM2). The hypothesis is that this patient-friendly physical therapist (PT)-guided exercise program associates with improved functional capacity and muscle compos...
What is the current status of trial NCT06716931?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-03-04. Estimated completion is 2026-03-01.
What conditions does trial NCT06716931 study?
This clinical trial studies the following conditions: Myotonic Dystrophy 2.
What interventions are being tested in trial NCT06716931?
The interventions under investigation include: Exercise (OTHER).
Who is sponsoring clinical trial NCT06716931?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06716931 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myotonic Dystrophy 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.